These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 9517375)

  • 1. Frequency and cost of serious adverse drug reactions in a department of general medicine.
    Moore N; Lecointre D; Noblet C; Mabille M
    Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic impact of adverse drug reactions in hospitalized patients.
    Suh DC; Woodall BS; Shin SK; Hermes-De Santis ER
    Ann Pharmacother; 2000 Dec; 34(12):1373-9. PubMed ID: 11144691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the direct cost of adverse drug reactions in hospitalised patients.
    Bordet R; Gautier S; Le Louet H; Dupuis B; Caron J
    Eur J Clin Pharmacol; 2001 Mar; 56(12):935-41. PubMed ID: 11317484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.
    Lagnaoui R; Moore N; Fach J; Longy-Boursier M; Bégaud B
    Eur J Clin Pharmacol; 2000 May; 56(2):181-6. PubMed ID: 10877014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
    Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
    Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
    Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
    van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
    Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty.
    Brvar M; Fokter N; Bunc M; Mozina M
    BMC Clin Pharmacol; 2009 May; 9():8. PubMed ID: 19409112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward.
    van Kraaij DJ; Haagsma CJ; Go IH; Gribnau FW
    Neth J Med; 1994 May; 44(5):166-73. PubMed ID: 8028691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readmissions and adverse drug reactions in internal medicine: the economic impact.
    Dormann H; Neubert A; Criegee-Rieck M; Egger T; Radespiel-Tröger M; Azaz-Livshits T; Levy M; Brune K; Hahn EG
    J Intern Med; 2004 Jun; 255(6):653-63. PubMed ID: 15147529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine.
    Fattinger K; Roos M; Vergères P; Holenstein C; Kind B; Masche U; Stocker DN; Braunschweig S; Kullak-Ublick GA; Galeazzi RL; Follath F; Gasser T; Meier PJ
    Br J Clin Pharmacol; 2000 Feb; 49(2):158-67. PubMed ID: 10671911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals.
    Zopf Y; Rabe C; Neubert A; Hahn EG; Dormann H
    Drug Saf; 2008; 31(9):789-98. PubMed ID: 18707193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
    Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
    Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.
    Franceschi M; Scarcelli C; Niro V; Seripa D; Pazienza AM; Pepe G; Colusso AM; Pacilli L; Pilotto A
    Drug Saf; 2008; 31(6):545-56. PubMed ID: 18484788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of outpatient adverse drug reactions leading to hospitalization.
    Wu WK; Pantaleo N
    Am J Health Syst Pharm; 2003 Feb; 60(3):253-9. PubMed ID: 12613234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Drug Reaction (ADR) as a Cause of Hospitalization at a Government Hospital in Saudi Arabia: A Prospective Observational Study.
    Alayed N; Alkhalifah B; Alharbi M; Alwohaibi N; Farooqui M
    Curr Drug Saf; 2019; 14(3):192-198. PubMed ID: 31109277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.